Methionine oxidation of amyloid peptides by peroxovanadium complexes: inhibition of fibril formation through a distinct mechanism
Open Access
- 1 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 7 (12) , 1562-1572
Abstract
Peroxovanadium complexes inhibit the fibril formation of neurodegenerative amyloid peptides by oxidizing methionine residues.Keywords
This publication has 60 references indexed in Scilit:
- Neurotoxicity of Prion Peptides Mimicking the Central Domain of the Cellular Prion ProteinPLOS ONE, 2013
- Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neuronsMolecular Neurodegeneration, 2012
- Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae In VitroJournal of Inorganic Biochemistry, 2012
- Anti-diabetic effects of vanadium(III, IV, V)–chlorodipicolinate complexes in streptozotocin-induced diabetic ratsBioMetals, 2009
- Core Structure of Amyloid Fibrils Formed by Residues 106–126 of the Human Prion ProteinStructure, 2009
- Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2008
- Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition MechanismChemical Biology & Drug Design, 2005
- Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein MutantsAnnals of the New York Academy of Sciences, 2000
- Molecular Characteristics of a Protease-Resistant, Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion ProteinBiochemical and Biophysical Research Communications, 1993
- Effects of vanadium on glucose metabolismLife Sciences, 1979